Trends in tumors in the central nervous system in elderly in Denmark, 2008–2012

References

• Globocan, http://globocan.iarc.fr/Default.aspx, 2012.
   Google Scholar
• Farrell CJ, Plotkin SR. Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes. Neurol Clin 2007;25:925–46, viii.
   PubMed Web of Science ®Google Scholar
• Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78–85.
   PubMed Web of Science ®Google Scholar
• Benson VS, Pirie K, Schuz J, Reeves GK, Beral V, Green J. Mobile phone use and risk of brain neoplasms and other cancers: prospective study. Int J Epidemiol 2013;42:792–802.
   PubMed Web of Science ®Google Scholar
• Hardell L, Carlberg M, Soderqvist F, Mild KH. Case-control study of the association between malignant brain tumours diagnosed between 2007 and 2009 and mobile and cordless phone use. Int J Oncol 2013;43:1833–45.
   PubMed Web of Science ®Google Scholar
• Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of Tumours of the Central Nervous System. International Agency for Research on cancer (IARC) 2007, 13–69.
   Google Scholar
• Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–96.
   PubMed Web of Science ®Google Scholar
• van den Bent MJ, Brandes AA, Taphoorn MJ, Kros JM, Kouwenhoven MC, Delattre JY, et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 2013;31:344–50.
   PubMed Web of Science ®Google Scholar
• Glantz M, Chamberlain M, Liu Q, Litofsky NS, Recht LD. Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer 2003;97:2262–6.
   PubMed Web of Science ®Google Scholar
• Malmstrom A, Gronberg BH, Marosi C, Stupp R, Frappaz D, Schultz H, et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol 2012;13:916–26.
   PubMed Web of Science ®Google Scholar
• Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 2012;13:707–15.
   PubMed Web of Science ®Google Scholar
• Roa W, Brasher PM, Bauman G, Anthes M, Bruera E, Chan A, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 2004;22:1583–8.
   PubMed Web of Science ®Google Scholar
• Ewertz M, Christensen K, Engholm G, Kejs A, Lund L, et al. Trends in cancer in the elderly population in Denmark, 1980-2012. Acta Oncol 2015;55: doi: 10.3109/0284186X.2015.1114678.
   Web of Science ®Google Scholar
• Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004;23:51–64.
   PubMed Web of Science ®Google Scholar
• Dahlrot RH, Kristensen BW, Hjelmborg J, Herrstedt J, Hansen S. A population-based study of high-grade gliomas and mutated isocitrate dehydrogenase 1. Int J Clin Exp Pathol 2013;6:31–40.
   PubMed Web of Science ®Google Scholar
• Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med 2007;356:1527–35.
   PubMed Web of Science ®Google Scholar
• Weller M, van den Bent M, Hopkins K, Tonn JC, Stupp R, Falini A, et al. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol 2014;15:e395–403.
   PubMed Web of Science ®Google Scholar
• Fiorica F, Berretta M, Colosimo C, Stefanelli A, Ursino S, Zanet E, et al. Glioblastoma in elderly patients: safety and efficacy of adjuvant radiotherapy with concomitant temozolomide. Arch Geront Geriatr 2010;51:31–5.
   PubMed Web of Science ®Google Scholar
• Gerstein J, Franz K, Steinbach JP, Seifert V, Fraunholz I, Weiss C, et al. Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma. Radiother Oncol 2010;97:382–6.
   PubMed Web of Science ®Google Scholar
• Gulati S, Jakola AS, Johannesen TB, Solheim O. Survival and treatment patterns of glioblastoma in the elderly: a population-based study. World Neurosurg 2012;78:518–26.
   PubMed Web of Science ®Google Scholar
• Smith GL, Smith BD. Radiation Treatment in Older Patients: A Framework for Clinical Decision Making. J Clin Oncol 2014;32:2669–78.
   PubMed Web of Science ®Google Scholar
• Wiestler B, Claus R, Hartlieb SA, Schliesser MG, Weiss EK, Hielscher T, et al. Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective. Neuro Oncol 2013;15:1017–26.
   PubMed Web of Science ®Google Scholar
• Chaichana KL, Jusue-Torres I, Navarro-Ramirez R, Raza SM, Pascual-Gallego M, Ibrahim A, et al. Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro Oncol 2014;16:113–22.
   PubMed Web of Science ®Google Scholar
• Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 2008;62:564–76. discussion -76.
   PubMed Web of Science ®Google Scholar
• Stummer W, Nestler U, Stockhammer F, Krex D, Kern BC, Mehdorn HM, et al. Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA. J Neurooncol 2011;103:361–70.
   PubMed Web of Science ®Google Scholar